Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.
Shopify (SHOP) shares have surged as much as 24% in Wednesday's trading session after the leading global commerce company reported strong Q2 results yesterday evening.
CVS Health Corp (CVS) delivered a 40% surge in adjusted EPS, raised its full-year outlook, and outlined a clear path to offset 2027 headwinds with strategic growth initiatives.
QBTS and RGTI report Q2 results tomorrow as investors watch bookings, revenue growth and commercial execution after strong April-June stock rallies.
HRMY tops Q2 estimates as Wakix demand fuels 30% revenue growth. A growing pipeline, BP-205 progress and reaffirmed 2026 guidance add momentum.
Toy Story 5 generated value across theaters, streaming, merchandise and parks as Disney's operating income jumped 21%.
Arista's revenue grew 38% as hyperscalers expanded the high-speed networks connecting increasingly powerful AI infrastructure.
GPN Q2 EPS beat estimates as Genius platform adoption lifts earnings, though revenues narrowly miss expectations.
Palantir reported solid Q2 results, with a $1.94 billion quarterly top line.
Sterling lifts its 2026 outlook as Q2 revenue jumps 90%, adjusted earnings more than double and backlog reaches $5.62 billion.
Sterling's surging backlog, mission-critical demand and margin gains bolster growth, but its premium valuation leaves little room for execution missteps.
DigitalOcean's Q2 revenues rise 28.6% as AI customer ARR surges 212%, prompting higher 2026 guidance despite lower year-over-year earnings.
Nvidia shares are getting a lift after some encouraging comments from SpaceX and Tesla CEO Elon Musk.
SNDR's Q2 earnings beat estimates as pricing, productivity and cost cuts lift profits and raise its 2026 outlook.
DVA's second-quarter 2026 results show profit growth, but narrowing margins and a weaker commercial mix weigh on the performance.
Zeta (ZETA) delivered earnings and revenue surprises of 5.00% and +5.36%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Inspire Medical's vast sleep apnea opportunity, rising margins and debt-free balance sheet support patience as reimbursement issues weigh on procedures.
Bitcoin’s price has struggled to break past $65,000 since the beginning of June, even hitting a 52-week low of around $57,700 in July.
The deal covers development, launch, and operation of Rocket Lab's flat satellite design as part of a broader $615 million award to three contractors
IPG Photonics beats Q2 earnings estimates as Industrial Solutions growth, led by battery manufacturing, lifts revenues and margins.
ALAB's Q2 earnings and revenues top estimates as PCIe 6 drives over half of sales and Scorpio X-Series ramp-up toward a stronger third quarter.
Advanced Energy's Q2 earnings beat as record semiconductor sales, AI-driven data center demand and factory execution lift revenues and margins.
CVS Health (CVS) is collaborating with Eli Lilly (LLY) as part of enhancements to its direct-to-cons
Three dividend stocks share the same cut-off deadline this week, meaning investors who wait even one extra day walk away with nothing. Here is what separates a timely income play from a missed opportunity.
Inspire Medical shares jumped 28.1% as an earnings beat, raised 2026 guidance and estimate revisions offset reimbursement pressure.
As stocks mark a 100 percentage-point gain from the start of the artificial-intelligence boom and hit all-time record highs, it might seem churlish to sound the alarm about dangers lurking beneath the surface. “ ‘Small vol’ events are going to affect markets with an increased frequency,” wrote Deutsche Bank analysts Luke Templeman and Galina Pozdnyakova in a recent client note. Last month’s effective liquidation at Leopold Aschenbrenner’s Situational Awareness, which saw around $16 billion in public stocks shifted to Citadel in a fire sale event, barely rippled markets.
H's Q2 earnings beat, faster fee growth and higher RevPAR outlook highlight operating momentum as regional weakness tests the pace of future gains.
H's fee growth and record pipeline support expansion, but a steep earnings multiple, project delays and debt make the stock a case for patience.
Zebra Technologies Corporation reported past second-quarter 2026 results with revenue rising to US$1,557 million and net income to US$233 million, driving basic earnings per share from continuing operations to US$4.89 from US$2.20 a year earlier. Alongside these record results, management raised full-year 2026 guidance for sales growth and profitability, pointing to broad-based demand and meaningful contributions from recent acquisitions such as Elo Touch. We'll now examine how Zebra's...
We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.
